Is Nipple-Sparing Mastectomy Indicated after Previous Breast Surgery? A Series of 387 Institutional Cases.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
01 Jul 2021
Historique:
entrez: 28 6 2021
pubmed: 29 6 2021
medline: 16 9 2021
Statut: ppublish

Résumé

Previous breast surgery does not represent an absolute contraindication for nipple-sparing mastectomy, although it may negatively interfere with surgical outcomes. The aim of the authors' study was to confirm the feasibility of nipple-sparing mastectomy after previous breast surgery, focusing on skin incisions and risk factors, complications, and oncologic outcomes. The authors retrospectively identified 368 patients who underwent 387 nipple-sparing mastectomies and reconstruction after previous surgery (quadrantectomy, breast resection, augmentation and reduction mammaplasty, mastopexy) at the European Institute of Oncology from January of 2003 to November of 2017. Patterns of skin incisions (i.e., radial, hemiperiareolar, periareolar, vertical pattern, inframammary fold, Wise-pattern, and round-block) for primary surgery and for mastectomy, type of reconstruction, and radiotherapy have been recorded. The authors collected data regarding early and late complications and further operations (implant change, fat grafting) performed within 2 years to improve cosmetic outcomes. Oncologic follow-up has been reported for in-breast recurrences. Complete and partial nipple-areola complex necrosis occurred, respectively, in 2.8 percent and in 5.4 percent of cases. The authors recorded 5.4 percent failures resulting in implant removal. The analysis of risk factors for complications or for the need for further operations showed no significant association with skin incision for first surgery and mastectomy, use of the same skin incision, previous radiotherapy, or type of primary surgery. Five-year overall survival and disease-free survival were 99.1 and 93.8 percent, respectively. No nipple recurrence was recorded. The authors' results confirm that nipple-sparing mastectomy can be a safe surgical procedure after previous breast surgery. Surgical planning should be tailored to each patient. Therapeutic, III.

Sections du résumé

BACKGROUND BACKGROUND
Previous breast surgery does not represent an absolute contraindication for nipple-sparing mastectomy, although it may negatively interfere with surgical outcomes. The aim of the authors' study was to confirm the feasibility of nipple-sparing mastectomy after previous breast surgery, focusing on skin incisions and risk factors, complications, and oncologic outcomes.
METHODS METHODS
The authors retrospectively identified 368 patients who underwent 387 nipple-sparing mastectomies and reconstruction after previous surgery (quadrantectomy, breast resection, augmentation and reduction mammaplasty, mastopexy) at the European Institute of Oncology from January of 2003 to November of 2017. Patterns of skin incisions (i.e., radial, hemiperiareolar, periareolar, vertical pattern, inframammary fold, Wise-pattern, and round-block) for primary surgery and for mastectomy, type of reconstruction, and radiotherapy have been recorded. The authors collected data regarding early and late complications and further operations (implant change, fat grafting) performed within 2 years to improve cosmetic outcomes. Oncologic follow-up has been reported for in-breast recurrences.
RESULTS RESULTS
Complete and partial nipple-areola complex necrosis occurred, respectively, in 2.8 percent and in 5.4 percent of cases. The authors recorded 5.4 percent failures resulting in implant removal. The analysis of risk factors for complications or for the need for further operations showed no significant association with skin incision for first surgery and mastectomy, use of the same skin incision, previous radiotherapy, or type of primary surgery. Five-year overall survival and disease-free survival were 99.1 and 93.8 percent, respectively. No nipple recurrence was recorded.
CONCLUSIONS CONCLUSIONS
The authors' results confirm that nipple-sparing mastectomy can be a safe surgical procedure after previous breast surgery. Surgical planning should be tailored to each patient.
CLINICAL QUESTION/LEVEL OF EVIDENCE METHODS
Therapeutic, III.

Identifiants

pubmed: 34181601
doi: 10.1097/PRS.0000000000008097
pii: 00006534-202107000-00005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-30

Informations de copyright

Copyright © 2021 by the American Society of Plastic Surgeons.

Références

Galimberti V, Vicini E, Corso G, et al. Nipple-sparing and skin-sparing mastectomy: Review of aims, oncological safety and contraindications. Breast. 2017;34Suppl 1S82–S84.
Smith BL, Tang R, Rai U, et al. Oncologic safety of nipple-sparing mastectomy in women with breast cancer. J Am Coll Surg. 2017;225:361–365.
Headon HL, Kasem A, Mokbel K. The oncological safety of nipple-sparing mastectomy: A systematic review of the literature with a pooled analysis of 12,358 procedures. Arch Plast Surg. 2016;43:328–338.
Agresti R, Sandri M, Gennaro M, et al. Evaluation of local oncologic safety in nipple-areola complex-sparing mastectomy after primary chemotherapy: A propensity score-matched study. Clin Breast Cancer. 2017;17:219–231.
Frey JD, Choi M, Karp NS. The effect of neoadjuvant chemotherapy compared to adjuvant chemotherapy in healing after nipple-sparing mastectomy. Plast Reconstr Surg. 2017;139:10e–19e.
Peled AW, Wang F, Foster RD, et al. Expanding the indications for total skin-sparing mastectomy: Is it safe for patients with locally advanced disease? Ann Surg Oncol. 2016;23:87–91.
Corso G, De Lorenzi F, Vicini E, et al. Nipple-sparing mastectomy with different approaches: Surgical incisions, complications, and cosmetic results. Preliminary results of 100 consecutive patients at a single center. J Plast Reconstr Aesthet Surg. 2018;71:1751–1760.
Frey JD, Salibian AA, Levine JP, Karp NS, Choi M. Incision choices in nipple-sparing mastectomy: A comparative analysis of outcomes and evolution of a clinical algorithm. Plast Reconstr Surg. 2018;142:826e–835e.
Murphy BL, Boughey JC, Hieken TJ. Nipple-sparing mastectomy for the management of recurrent breast cancer. Clin Breast Cancer. 2017;17:e209–e213.
Lee CH, Cheng MH, Wu CW, Kuo WL, Yu CC, Huang JJ. Nipple-sparing mastectomy and immediate breast reconstruction after recurrence from previous breast conservation therapy. Ann Plast Surg. 2019;82Suppl 1S95–S102.
Alperovich M, Choi M, Frey JD, et al. Nipple-sparing mastectomy in patients with prior breast irradiation: Are patients at higher risk for reconstructive complications? Plast Reconstr Surg. 2014;134:202e–206e.
Park JE, Song DH. Discussion: Nipple-sparing mastectomy in patients with prior breast irradiation: Are patients at higher risk for reconstructive complications? Plast Reconstr Surg. 2014;134:207e–208e.
Chirappapha P, Petit JY, Rietjens M, et al. Nipple sparing mastectomy: Does breast morphological factor related to necrotic complications? Plast Reconstr Surg Glob Open. 2014;2:e99.
Toesca A, Peradze N, Manconi A, et al. Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study. Breast. 2017;31:51–56.
Frederick MJ, Lin AM, Neuman R, Smith BL, Austen WG Jr, Colwell AS. Nipple-sparing mastectomy in patients with previous breast surgery: Comparative analysis of 775 immediate breast reconstructions. Plast Reconstr Surg. 2015;135:954e–962e.
Dent BL, Cordeiro CN, Small K, et al. Nipple-sparing mastectomy via an inframammary fold incision with implant-based reconstruction in patients with prior cosmetic breast surgery. Aesthet Surg J. 2015;35:548–557.
Alperovich M, Tanna N, Samra F, et al. Nipple-sparing mastectomy in patients with a history of reduction mammaplasty or mastopexy: How safe is it? Plast Reconstr Surg. 2013;131:962–967.
Spear SL, Rottman SJ, Seiboth LA, Hannan CM. Breast reconstruction using a staged nipple-sparing mastectomy following mastopexy or reduction. Plast Reconstr Surg. 2012;129:572–581.
Economides JM, Graziano F, Tousimis E, Willey S, Pittman TA. Expanded algorithm and updated experience with breast reconstruction using a staged nipple-sparing mastectomy following mastopexy or reduction mammaplasty in the large or ptotic breast. Plast Reconstr Surg. 2019;143:688e–697e.
Thorek P. Reduction mammaplasty for pendulous breasts. GP. 1963;27:95–102.
Jensen JA, Lin JH, Kapoor N, Giuliano AE. Surgical delay of the nipple-areolar complex: A powerful technique to maximize nipple viability following nipple-sparing mastectomy. Ann Surg Oncol. 2012;19:3171–3176.
Galimberti V, Morigi C, Bagnardi V, et al. Oncological outcomes of nipple-sparing mastectomy: A single-center experience of 1989 patients. Ann Surg Oncol. 2018;25:3849–3857.
Daar DA, Abdou SA, Rosario L, et al. Is there a preferred incision location for nipple-sparing mastectomy? A systematic review and meta-analysis. Plast Reconstr Surg. 2019;143:906e–919e.
Donovan CA, Harit AP, Chung A, Bao J, Giuliano AE, Amersi F. Oncological and surgical outcomes after nipple-sparing mastectomy: Do incisions matter? Ann Surg Oncol. 2016;23:3226–3231.
Radovanovic Z, Ranisavljevic M, Radovanovic D, Vicko F, Ivkovic-Kapicl T, Solajic N. Nipple-sparing mastectomy with primary implant reconstruction: Surgical and oncological outcome of 435 breast cancer patients. Breast Care (Basel). 2018;13:373–378.
Colwell AS, Tessler O, Lin AM, et al. Breast reconstruction following nipple-sparing mastectomy: Predictors of complications, reconstruction outcomes, and 5-year trends. Plast Reconstr Surg. 2014;133:496–506.
De Lorenzi F, Lohsiriwat V, Barbieri B, et al. Immediate breast reconstruction with prostheses after conservative treatment plus intraoperative radiotherapy: Long term esthetic and oncological outcomes. Breast. 2012;21:374–379.
Chang DW, Barnea Y, Robb GL. Effects of an autologous flap combined with an implant for breast reconstruction: An evaluation of 1000 consecutive reconstructions of previously irradiated breasts. Plast Reconstr Surg. 2008;122:356–362.
Fischer JP, Basta MN, Shubinets V, Serletti JM, Fosnot J. A systematic meta-analysis of prosthetic-based breast reconstruction in irradiated fields with or without autologous muscle flap coverage. Ann Plast Surg. 2016;77:129–134.
Clemens MW, Kronowitz SJ. Acellular dermal matrix in irradiated tissue expander/implant-based breast reconstruction: Evidence-based review. Plast Reconstr Surg. 2012;130Suppl 227S–34S.
Valdatta L, Cattaneo AG, Pellegatta I, Scamoni S, Minuti A, Cherubino M. Acellular dermal matrices and radiotherapy in breast reconstruction: A systematic review and meta-analysis of the literature. Plast Surg Int. 2014;2014:472604.
Tang R, Coopey SB, Colwell AS, et al. Nipple-sparing mastectomy in irradiated breasts: Selecting patients to minimize complications. Ann Surg Oncol. 2015;22:3331–3337.
Brambullo T, Dalla Venezia E, Martella S, et al. Conservative mastectomy versus nipple-sparing mastectomy: Preliminary considerations of oncological safety on 30 patients not receiving intra-operative radiotherapy. Gland Surg. 2017;6:654–658.
Jeon FHK, Varghese J, Griffin M, Butler PE, Ghosh D, Mosahebi A. Systematic review of methodologies used to assess mastectomy flap viability. BJS Open. 2018;2:175–184.
Peled AW, Amara D, Piper ML, Klassen AF, Tsangaris E, Pusic AL. Development and validation of a nipple-specific scale for the BREAST-Q to assess patient-reported outcomes following nipple-sparing mastectomy. Plast Reconstr Surg. 2019;143:1010–1017.

Auteurs

Elisa Vicini (E)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Francesca De Lorenzi (F)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Alessandra Invento (A)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Giovanni Corso (G)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Davide Radice (D)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Samantha Bozzo (S)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Sabrina Kahler Ribeiro Fontana (S)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Pietro Caldarella (P)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Paolo Veronesi (P)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Viviana Galimberti (V)

From the Divisions of Breast Surgery, Plastic and Reconstructive Surgery, and Epidemiology and Biostatistics, European Institute of Oncology IRCCS; the Department of Oncology and Hematology-Oncology, University of Milan; and the Universidade Federal do Rio Grande do Sul.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH